ZVLL-CHO at low concentrations acts as a calpain inhibitor to protect neurons against okadaic acid-induced neurodegeneration

Neuroscience Letters

Volumn 509, Issue 1, 2012, Pages 33-38

  Yoon, Seung Yong ^a   Choi, Jung Eun ^a   Ham, Ju Hee ^a   Choe, Han ^a   Lee, Hui Sun ^a   Kim, Dong Hou ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Alzheimer's disease; Calpain; Okadaic acid; PP2A; ZVLL CHO

Indexed keywords

BETA SECRETASE; BETA SECRETASE INHIBITOR; CALPAIN; CALPASTATIN; FODRIN; GL 189; LACTATE DEHYDROGENASE; N BENZYLOXYCARBONYLVALYLLEUCYLLEUCINAL; NEUROPROTECTIVE AGENT; OKADAIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL LEVEL; CELL SIZE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENDRITE; EMBRYO; ENZYME INHIBITION; ENZYME RELEASE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; RAT;

AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; CALPAIN; CELLS, CULTURED; CYSTEINE PROTEINASE INHIBITORS; L-LACTATE DEHYDROGENASE; NEURONS; NEUROPROTECTIVE AGENTS; OKADAIC ACID; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; RATS; SPECTRIN;

EID: 84862826324     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.12.042     Document Type: Article

References (34)

1. Chen M., Durr J., Fernandez H.L. Possible role of calpain in normal processing of beta-amyloid precursor protein in human platelets. Biochem. Biophys. Res. Commun. 2000, 273:170-175.
2. Chen M., Fernandez H.L. Mu-calpain is functionally required for alpha-processing of Alzheimer's beta-amyloid precursor protein. Biochem. Biophys. Res. Commun. 2005, 330:714-721.
3. Chen M., Fernandez H.L. Stimulation of beta-amyloid precursor protein alpha-processing by phorbol ester involves calcium and calpain activation. Biochem. Biophys. Res. Commun. 2004, 316:332-340.
4. Citron M., Diehl T.S., Gordon G., Biere A.L., Seubert P., Selkoe D.J. Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:13170-13175.
5. Cole S.L., Vassar R. The role of amyloid precursor protein processing by BACE1, the beta-secretase, in Alzheimer disease pathophysiology. J. Biol. Chem. 2008, 283:29621-29625.
6. Czvitkovich S., Duller S., Mathiesen E., Lorenzoni K., Imbimbo B.P., Hutter-Paier B., Windisch M., Wronski R. Comparison of pharmacological modulation of APP metabolism in primary chicken telencephalic neurons and in a human neuroglioma cell line. J. Mol. Neurosci. 2011, 43:257-267.
7. Ermolieff J., Loy J.A., Koelsch G., Tang J. Proteolytic activation of recombinant pro-memapsin 2 (Pro-beta-secretase) studied with new fluorogenic substrates. Biochemistry 2000, 39:12450-12456.
8. Figueiredo-Pereira M.E., Efthimiopoulos S., Tezapsidis N., Buku A., Ghiso J., Mehta P., Robakis N.K. Distinct secretases, a cysteine protease and a serine protease, generate the C termini of amyloid beta-proteins Abeta1-40 and Abeta1-42, respectively. J. Neurochem. 1999, 72:1417-1422.
9. Gong C.X., Lidsky T., Wegiel J., Zuck L., Grundke-Iqbal I., Iqbal K. Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J. Biol. Chem. 2000, 275:5535-5544.
10. Gong C.X., Shaikh S., Wang J.Z., Zaidi T., Grundke-Iqbal I., Iqbal K. Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. J. Neurochem. 1995, 65:732-738.
11. Holsinger R.M., McLean C.A., Beyreuther K., Masters C.L., Evin G. Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease. Ann. Neurol. 2002, 51:783-786.
12. Kienlen-Campard P., Feyt C., Huysseune S., de Diesbach P., N'Kuli F., Courtoy P.J., Octave J.N. Lactacystin decreases amyloid-beta peptide production by inhibiting beta-secretase activity. J. Neurosci. Res. 2006, 84:1311-1322.
13. Kim D., Su J., Cotman C.W. Sequence of neurodegeneration and accumulation of phosphorylated tau in cultured neurons after okadaic acid treatment. Brain Res. 1999, 839:253-262.
14. Klafki H., Abramowski D., Swoboda R., Paganetti P.A., Staufenbiel M. The carboxyl termini of beta-amyloid peptides 1-40 and 1-42 are generated by distinct gamma-secretase activities. J. Biol. Chem. 1996, 271:28655-28659.
15. Koh Y.H., von Arnim C.A., Hyman B.T., Tanzi R.E., Tesco G. BACE is degraded via the lysosomal pathway. J. Biol. Chem. 2005, 280:32499-32504.
16. Li R., Lindholm K., Yang L.B., Yue X., Citron M., Yan R., Beach T., Sue L., Sabbagh M., Cai H., Wong P., Price D., Shen Y. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:3632-3637.
17. Liang B., Duan B.Y., Zhou X.P., Gong J.X., Luo Z.G. Calpain activation promotes BACE1 expression, amyloid precursor protein processing, and amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J. Biol. Chem. 2010, 285:27737-27744.
18. Mathews P.M., Jiang Y., Schmidt S.D., Grbovic O.M., Mercken M., Nixon R.A. Calpain activity regulates the cell surface distribution of amyloid precursor protein. Inhibition of calpains enhances endosomal generation of beta-cleaved C-terminal APP fragments. J. Biol. Chem. 2002, 277:36415-36424.
19. Matsuo E.S., Shin R.W., Billingsley M.L., Van deVoorde A., O'Connor M., Trojanowski J.Q., Lee V.M. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron 1994, 13:989-1002.
20. Nimmrich V., Reymann K.G., Strassburger M., Schoder U.H., Gross G., Hahn A., Schoemaker H., Wicke K., Moller A. Inhibition of calpain prevents NMDA-induced cell death and beta-amyloid-induced synaptic dysfunction in hippocampal slice cultures. Br. J. Pharmacol. 2010, 159:1523-1531.
21. Saito K., Elce J.S., Hamos J.E., Nixon R.A. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:2628-2632.
22. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 2001, 81:741-766.
23. Siman R., Baudry M., Lynch G. Brain fodrin: substrate for calpain I, an endogenous calcium-activated protease. Proc. Natl. Acad. Sci. U. S. A. 1984, 81:3572-3576.
24. Sontag E., Hladik C., Montgomery L., Luangpirom A., Mudrak I., Ogris E., White C.L. Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to Alzheimer disease pathogenesis. J. Neuropathol. Exp. Neurol. 2004, 63:1080-1091.
25. Sun L., Liu S.Y., Zhou X.W., Wang X.C., Liu R., Wang Q., Wang J.Z. Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats. Neuroscience 2003, 118:1175-1182.
26. Tanimukai H., Grundke-Iqbal I., Iqbal K. Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease. Am. J. Pathol. 2005, 166:1761-1771.
27. Vogelsberg-Ragaglia V., Schuck T., Trojanowski J.Q., Lee V.M. PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus. Exp. Neurol. 2001, 168:402-412.
28. Williams A., Sarkar S., Cuddon P., Ttofi E.K., Saiki S., Siddiqi F.H., Jahreiss L., Fleming A., Pask D., Goldsmith P., O'Kane C.J., Floto R.A., Rubinsztein D.C. Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. Nat. Chem. Biol. 2008, 4:295-305.
29. Yang L.B., Lindholm K., Yan R., Citron M., Xia W., Yang X.L., Beach T., Sue L., Wong P., Price D., Li R., Shen Y. Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat. Med. 2003, 9:3-4.
30. Yoon S., Choi J., Haam J., Choe H., Kim D. Reduction of mint-1, mint-2, and APP overexpression in okadaic acid-treated neurons. Neuroreport 2007, 18:1879-1883.
31. Yoon S., Choi J., Huh J.W., Hwang O., Kim D. Calpain activation in okadaic-acid-induced neurodegeneration. Neuroreport 2006, 17:689-692.
32. Yoon S.Y., Choi J.E., Yoon J.H., Huh J.W., Kim D.H. BACE inhibitor reduces APP-beta-C-terminal fragment accumulation in axonal swellings of okadaic acid-induced neurodegeneration. Neurobiol. Dis. 2006, 22:435-444.
33. Yu W.H., Cuervo A.M., Kumar A., Peterhoff C.M., Schmidt S.D., Lee J.H., Mohan P.S., Mercken M., Farmery M.R., Tjernberg L.O., Jiang Y., Duff K., Uchiyama Y., Naslund J., Mathews P.M., Cataldo A.M., Nixon R.A. Macroautophagy-a novel beta-amyloid peptide-generating pathway activated in Alzheimer's disease. J. Cell Biol. 2005, 171:87-98.
34. Zhang L., Song L., Parker E.M. Calpain inhibitor I increases beta-amyloid peptide production by inhibiting the degradation of the substrate of gamma-secretase. Evidence that substrate availability limits beta-amyloid peptide production. J. Biol. Chem. 1999, 274:8966-8972.